Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH AL 2020 | Diagnostic strategies for Ph-like ALL

Sarah Tasian • 26 Jun 2020
ESH AL 2020
Acute Lymphoblastic Leukemia Leukemia

Sarah Tasian, MD, Children’s Hospital of Philadelphia, Philadelphia, PA, discusses the available diagnostic testing modalities for patients with Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL), including a practical clinical algorithm to facilitate the identification and allocation of patients to appropriate therapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Sarah Tasian

1:09
Precision medicine in pediatric ALL
Sarah Tasian • 4 Jun 2023
1:16
Pediatric leukemia at ASCO 2023
Sarah Tasian • 4 Jun 2023
0:54
Clinical responses of pediatric patients with R/R acute leukemia treated with aza/ven
Sarah Tasian • 16 Apr 2023
0:56
Improving therapeutic approaches for patients with Ph-like ALL & the importance of disease biology
Sarah Tasian • 16 Apr 2023

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals